Qube Research & Technologies (QRT)’s Fennec Pharmaceuticals FENC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$627K	Buy	58,292 +28,914	+98%	+$236K	﹤0.01%	2584
2026 Q1	$181K	Sell	29,378 -15,314	-34%	-$118K	﹤0.01%	2978
2025 Q4	$344K	Buy	+44,692	New	+$367K	﹤0.01%	2907
2025 Q1	–	Sell	-21,938	Closed	-$139K	–	3603
2024 Q4	$139K	Sell	21,938 -26,776	-55%	-$137K	﹤0.01%	2921
2024 Q3	$244K	Buy	48,714 +1,730	+4%	+$10K	﹤0.01%	2514
2024 Q2	$287K	Buy	46,984 +38,100	+429%	+$316K	﹤0.01%	2324
2024 Q1	$98.8K	Buy	+8,884	New	+$89.2K	﹤0.01%	3303
2023 Q2	–	Sell	-40,195	Closed	-$334K	–	2579
2023 Q1	$334K	Buy	40,195 +22,923	+133%	+$213K	﹤0.01%	1708
2022 Q4	$166K	Buy	+17,272	New	+$153K	﹤0.01%	1870

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FENC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Fennec Pharmaceuticals (FENC) stake by 98% in Q2 2026, buying an estimated $236K and bringing the position to 58,292 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

Qube Research & Technologies (QRT) first reported a position in FENC in Q4 2022 and has held it in 9 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Qube Research & Technologies (QRT) held 58,292 shares of Fennec Pharmaceuticals worth $627K as of Q2 2026.
Qube Research & Technologies (QRT) bought 28,914 Fennec Pharmaceuticals shares in Q2 2026, an estimated $236K.
Fennec Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2584 holding.
Qube Research & Technologies (QRT) first reported a position in Fennec Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.